Acadian Asset Management’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
ACM
RA
BPC
AIC
SCM
SAM
Acadian Asset Management's SOPH Position: Q2 2026 in Review
Acadian Asset Management opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 22,600 shares worth $129K. The stake represents ﹤0.01% of the portfolio and ranks #1710 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in SOPH as recently as Q4 2025.
Acadian Asset Management first reported a position in SOPH in Q4 2025 and has held it in 2 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- Acadian Asset Management held 22,600 shares of SOPHiA GENETICS worth $129K as of Q2 2026.
- SOPHiA GENETICS was a new Acadian Asset Management position in Q2 2026.
- SOPHiA GENETICS made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1710 holding.
- Acadian Asset Management first reported a position in SOPHiA GENETICS in Q4 2025 and has held it in 2 quarters since.
- 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.